nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—scrotum—vulva cancer	0.702	0.702	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—vulva cancer	0.0556	0.0556	CbGeAlD
Nandrolone phenpropionate—AR—uterine cervix—vulva cancer	0.0551	0.0551	CbGeAlD
Nandrolone phenpropionate—AR—urethra—vulva cancer	0.0506	0.0506	CbGeAlD
Nandrolone phenpropionate—AR—mammalian vulva—vulva cancer	0.0482	0.0482	CbGeAlD
Nandrolone phenpropionate—AR—vagina—vulva cancer	0.0373	0.0373	CbGeAlD
Nandrolone phenpropionate—CYP19A1—lymph node—vulva cancer	0.0273	0.0273	CbGeAlD
Nandrolone phenpropionate—AR—lymph node—vulva cancer	0.0241	0.0241	CbGeAlD
